1-2 of 2
Heinz Dürk
Close
Save search
Sort by
Journal Articles

How Much Rituximab Do We Need: A Multicenter, Randomized Trial Comparing 1, 3 or 6 Infusions of Rituximab Combined with 6 Cycles of CHOP Chemotherapy in Untreated Patients with Advanced Follicular Lymphoma (HD2000-Trial).

Free
Fabienne McClanahan, MD, Thomas Hielscher, Michael Rieger, MD, Manfred Hensel, MD, PhD, Martin Bentz, MD, Ingo Schmidt-Wolf, Andreas Kaebisch, MD, Hans-Jürgen Salwender, Heinz Dürk, Hans Juergen Staiger, MD, Thomas Mandel, MD, Kai Neben, MD, Jens Hillengass, MD, Anthony D. Ho, MD, PhD, Mathias Witzens-Harig, MD
Journal: Blood
Blood (2009) 114 (22): 2687.
https://doi.org/10.1182/blood.V114.22.2687.2687
Published: 2009
Journal Articles

Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial).

Free
Hermann Einsele, Peter Liebisch, Christian Langer, Martin Kropff, Hannes Wandt, Wolfram Jung, Nikolaus Kröger, Monika Engelhardt, Helmut Ostermann, Lars-Olof Mügge, Hans-Heinrich Wolf, Christina Hart, Bernd Metzner, Martin Kaufmann, Martin Gramatzki, Bernd Hertenstein, Thomas Fischer, Katja Weisel, Gottfried Dölken, Wolfram Brugger, Hella Gollasch, Georg Maschmeyer, Michael Pfreundschuh, Norbert Schmitz, Orhan Sezer, Else Heidemann, Elke Jäger, Christoph Kahl, Alexander Kiani, Tobias Dechow, Wolf Rösler, Jan Philipp Simon, Heinz Dürk, Karl Heinz Pflüger, Martin Bentz, Georg Hess, Hans-Guenther Mergenthaler, Christian Straka, Dirk Hempel, Hans-Jürgen Salwender, Günter Fingerle-Rowson, Stefan Knop
Journal: Blood
Blood (2009) 114 (22): 131.
https://doi.org/10.1182/blood.V114.22.131.131
Published: 2009